tiprankstipranks
Trending News
More News >
Cartesian Therapeutics (RNAC)
NASDAQ:RNAC

Compare Cartesian Therapeutics (RNAC) vs. Competitors

Compare
1,145 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Cartesian Therapeutics
$7.27
$213.23M
-0.14
-58.21%
6 Buy
2 Hold
0 Sell
Strong Buy
Puma Biotechnology
$6.28
$307.89M
8.48
102.60%
0 Buy
1 Hold
1 Sell
Moderate Sell
DBV Technologies SA - American
$17.93
$707.76M
-3.42
214.79%
5 Buy
0 Hold
0 Sell
Strong Buy
Voyager Therapeutics
$3.90
$223.51M
-1.80
-23.86%
7 Buy
0 Hold
0 Sell
Strong Buy
Atea Pharmaceuticals
$3.61
$269.54M
-2.03
9.69%
2 Buy
0 Hold
0 Sell
Moderate Buy
Vor Biopharma
$14.15
$296.23M
-0.04
-50.77%
6 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RNAC
Cartesian Therapeutics
7.66
-11.29
-59.58%
PBYI
Puma Biotechnology
6.24
3.17
103.26%
DBVT
DBV Technologies SA - American
17.03
12.17
250.41%
VYGR
Voyager Therapeutics
4.02
-1.17
-22.54%
AVIR
Atea Pharmaceuticals
3.51
0.19
5.72%
VOR
Vor Biopharma
13.49
-13.91
-50.77%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts